Moderna (MRNA) May weekly 130 straddle into results

Go back to Moderna (MRNA) May weekly 130 straddle into results

Moderna (MRNA) Q1 earnings, revenue surprisingly tops consensus estimates

May 4, 2023 9:50 AM EDT

Moderna (NASDAQ: MRNA) shares opened higher Thursday on the back of its surprising earnings and revenue beat.

The drugmaker had been expected to post a $1.75 loss in the quarter, however, it reported Q1 EPS of $0.19, topping expectations by $1.94. In addition, revenue... More